February 1, 2024 · Form 4 insider transaction
Doherty James J. bought 601,000 shares of Acumen Pharmaceuticals, Inc. Company: Acumen Pharmaceuticals, Inc. (San Francisco, CA) Description: Drug Discovery at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on February 1, 2025, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date.